Abstract
Seasonal immunisation against respiratory syncytial virus disease
Highlights
Respiratory syncytial virus (RSV) causes a major burden of disease in children, especially within the first year of life.[1]
In line with previous studies,[1] the highest burden occurred in infants younger than 6 months, with a nine-fold higher risk of being admitted to hospital and a two-fold higher risk of needing to visit a general practitioner (GP), compared with children aged between 6 months and 5 years
Cromer and colleagues’ study[3] underscores the need for maternal and newborn immunisation. Their findings suggest that there are advantages to seasonal immunisation for RSV, since epidemics of the disease have a seasonal pattern in countries with temperate climates.[4]
Summary
Respiratory syncytial virus (RSV) causes a major burden of disease in children, especially within the first year of life.[1].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.